RELENZA IV

Swiss trademark · 660660 · Word mark · In force

Register entry

Registration number
660660
Application number
51834/2014
Status
In force
Type
Word mark
Filed
Feb 13, 2014
Registered
Jun 26, 2014
Published
Jun 26, 2014
Protected until
Feb 13, 2034
Language of procedure
French
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmaceutical and medical preparations and substances; Vaccines

As filed

Pharmazeutische und medizinische Präparate und Substanzen; Impfstoffe.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 26, 2024

    Agent’s address changed

    Representative
    AWA SWITZERLAND SA, 2, rue de la Faïencerie, 1227 Carouge, Genève → AWA Switzerland SA, Rue de la Faïencerie 2, 1227 Carouge GE

    Published in Swissreg on 26.09.2024

  2. Dec 21, 2023

    Renewed

    Published in Swissreg on 21.12.2023

  3. Sep 21, 2023

    Holder’s address changed

    Owner
    Glaxo Group Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom → Glaxo Group Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom

    Published in Swissreg on 21.09.2023

  4. Jun 24, 2022

    Agent removed

    Representative
    Wild Schnyder AG, Forchstrasse 30, P.O. Box 1067, 8032 Zürich (removed)

    Published in Swissreg on 24.06.2022

  5. Jun 24, 2022

    Agent entered

    Representative
    AWA SWITZERLAND SA, 2, rue de la Faïencerie, 1227 Carouge, Genève

    Published in Swissreg on 24.06.2022

  6. Jun 26, 2014

    Registered

    Published in Swissreg on 26.06.2014

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.